Extended Data Fig. 4: Immune cell diversity in the nasal mucosa during SARS-CoV-2 infection.
From: Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2
a) UMAP of 5,408 immune cells from all participants colored by major immune cell type as identified in Fig. 1d. b-c) UMAPs of detailed subclusters within (b) T cells (n = 112 participants, 2,705 cells) and (c) myeloid cells (n = 112 participants, 2,535 cells). Cells from all participants belonging to that cell type were sub-clustered with louvain clustering. See Supplementary Table 5 for full lists of subset marker genes. d) Violin plot of marker genes for each immune subset.
